Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125505673 | 12550567 | 3 | F | 20160302 | 20160821 | 20160712 | 20160823 | PER | US-PFIZER INC-2016326939 | PFIZER | 78.00 | YR | F | Y | 99.79000 | KG | 20160823 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125505673 | 12550567 | 1 | PS | LYRICA | PREGABALIN | 1 | 50 MG 2, TWICE A DAY | Y | 21446 | 100 | MG | CAPSULE, HARD | BID | ||||||
125505673 | 12550567 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 2 DF, 2X/DAY (2 TABLETS IN THE MORNING AND 2 TABLETS IN THE EVENING BY MOUTH) | Y | 20882 | 2 | DF | FILM-COATED TABLET | BID | |||||
125505673 | 12550567 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | UNK | Y | 20882 | FILM-COATED TABLET | |||||||||
125505673 | 12550567 | 4 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | [HYDROCODONE 5MG]/[PARACETAMOL 325MG], AS NEEDED (5-325MG TABLET 1-2 BY MOUTH AS NEEDED) | 0 | |||||||||||
125505673 | 12550567 | 5 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK | 0 | |||||||||||
125505673 | 12550567 | 6 | C | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
125505673 | 12550567 | 7 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Oral | 60 MG, 1X/DAY, IN THE MORNING | 0 | 60 | MG | TABLET | QD | ||||||
125505673 | 12550567 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 75 UG, 1X/DAY | 0 | 75 | UG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125505673 | 12550567 | 1 | Neuralgia |
125505673 | 12550567 | 2 | Neuralgia |
125505673 | 12550567 | 4 | Pain |
125505673 | 12550567 | 6 | Blood pressure abnormal |
125505673 | 12550567 | 7 | Blood pressure abnormal |
125505673 | 12550567 | 8 | Hypothyroidism |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125505673 | 12550567 | Gait disturbance | |
125505673 | 12550567 | Musculoskeletal pain | |
125505673 | 12550567 | Neuralgia | |
125505673 | 12550567 | Pain | |
125505673 | 12550567 | Pain in extremity | |
125505673 | 12550567 | Peripheral swelling | |
125505673 | 12550567 | Product use issue | |
125505673 | 12550567 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125505673 | 12550567 | 1 | 20160402 | 20160710 | 0 | |
125505673 | 12550567 | 2 | 20160302 | 20160402 | 0 | |
125505673 | 12550567 | 3 | 20160302 | 20160402 | 0 | |
125505673 | 12550567 | 4 | 20160302 | 20160402 | 0 | |
125505673 | 12550567 | 5 | 20160302 | 20160402 | 0 |